Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 1
2004 1
2005 1
2006 1
2008 1
2009 2
2010 3
2011 4
2012 1
2013 4
2014 3
2015 7
2016 6
2017 9
2018 5
2019 4
2020 7
2021 8
2022 19
2023 12
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

88 results

Results by year

Filters applied: . Clear all
Page 1
Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial.
Heerspink HJL, Radhakrishnan J, Alpers CE, Barratt J, Bieler S, Diva U, Inrig J, Komers R, Mercer A, Noronha IL, Rheault MN, Rote W, Rovin B, Trachtman H, Trimarchi H, Wong MG, Perkovic V; PROTECT Investigators. Heerspink HJL, et al. Lancet. 2023 May 13;401(10388):1584-1594. doi: 10.1016/S0140-6736(23)00569-X. Epub 2023 Apr 1. Lancet. 2023. PMID: 37015244 Clinical Trial.
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial.
Rovin BH, Barratt J, Heerspink HJL, Alpers CE, Bieler S, Chae DW, Diva UA, Floege J, Gesualdo L, Inrig JK, Kohan DE, Komers R, Kooienga LA, Lafayette R, Maes B, Małecki R, Mercer A, Noronha IL, Oh SW, Peh CA, Praga M, Preciado P, Radhakrishnan J, Rheault MN, Rote WE, Tang SCW, Tesar V, Trachtman H, Trimarchi H, Tumlin JA, Wong MG, Perkovic V; DUPRO steering committee and PROTECT Investigators. Rovin BH, et al. Lancet. 2023 Dec 2;402(10417):2077-2090. doi: 10.1016/S0140-6736(23)02302-4. Epub 2023 Nov 3. Lancet. 2023. PMID: 37931634 Clinical Trial.
Immunological Effects of a Single Hemodialysis Treatment.
Angeletti A, Zappulo F, Donadei C, Cappuccilli M, Di Certo G, Conte D, Comai G, Donati G, La Manna G. Angeletti A, et al. Among authors: donati g. Medicina (Kaunas). 2020 Feb 12;56(2):71. doi: 10.3390/medicina56020071. Medicina (Kaunas). 2020. PMID: 32059426 Free PMC article. Review.
Silver-positive kidney AL amyloidosis.
Fontana F, Alfano G, Verga L, Magistroni R, Donati G. Fontana F, et al. Among authors: donati g. J Nephrol. 2024 Jan 22. doi: 10.1007/s40620-023-01827-1. Online ahead of print. J Nephrol. 2024. PMID: 38252262 No abstract available.
Rethinking Chronic Kidney Disease in the Aging Population.
Alfano G, Perrone R, Fontana F, Ligabue G, Giovanella S, Ferrari A, Gregorini M, Cappelli G, Magistroni R, Donati G. Alfano G, et al. Among authors: donati g. Life (Basel). 2022 Oct 28;12(11):1724. doi: 10.3390/life12111724. Life (Basel). 2022. PMID: 36362879 Free PMC article. Review.
Hepatorenal syndrome: Update on diagnosis and treatment.
Baraldi O, Valentini C, Donati G, Comai G, Cuna V, Capelli I, Angelini ML, Moretti MI, Angeletti A, Piscaglia F, La Manna G. Baraldi O, et al. Among authors: donati g. World J Nephrol. 2015 Nov 6;4(5):511-20. doi: 10.5527/wjn.v4.i5.511. World J Nephrol. 2015. PMID: 26558188 Free PMC article. Review.
Assessment and Management of Transplant Renal Artery Stenosis. A Literature Review.
Pini A, Faggioli G, Pini R, Mauro R, Gallitto E, Mascoli C, Grandinetti V, Donati G, Odaldi F, Ravaioli M, La Manna G, Gargiulo M. Pini A, et al. Among authors: donati g. Ann Vasc Surg. 2022 May;82:13-29. doi: 10.1016/j.avsg.2022.01.011. Epub 2022 Jan 31. Ann Vasc Surg. 2022. PMID: 35108560 Free article. Review.
88 results